Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic miceRyu‐Ichiro Hata(Kanagawa Dental University), Masaru Taniguchi(RIKEN Center for Integrative Medical Sciences)Scientific ReportsMarch 13, 201510.1038/srep09083Cited by 44SaveCiteExport RISWatch citationsRelated PapersRestoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma|Cancer Science|2009|44